91 related articles for article (PubMed ID: 21959331)
1. The antitumor immunopreventive effects of a DNA vaccine against CYP26a1 on mouse breast carcinoma.
Wang RC; Liu ZK; Chen W; Yang Y; Peng JP
Vaccine; 2011 Nov; 29(48):8915-23. PubMed ID: 21959331
[TBL] [Abstract][Full Text] [Related]
2. Nicotine-mediated suppression of the retinoic acid metabolizing enzyme CYP26A1 limits the oncogenic potential of breast cancer.
Osanai M; Lee GH
Cancer Sci; 2011 Jun; 102(6):1158-63. PubMed ID: 21371177
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antitumor efficacy of combined DNA vaccines targeting tumor cells and angiogenesis.
Yin X; Wang W; Zhu X; Wang Y; Wu S; Wang Z; Wang L; Du Z; Gao J; Yu J
Biochem Biophys Res Commun; 2015 Sep; 465(2):239-44. PubMed ID: 26253468
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid-metabolizing enzyme cytochrome P450 26a1 (cyp26a1) is essential for implantation: functional study of its role in early pregnancy.
Han BC; Xia HF; Sun J; Yang Y; Peng JP
J Cell Physiol; 2010 May; 223(2):471-9. PubMed ID: 20112286
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid metabolizing enzyme CYP26A1 is implicated in rat embryo implantation.
Xia HF; Ma JJ; Sun J; Yang Y; Peng JP
Hum Reprod; 2010 Dec; 25(12):2985-98. PubMed ID: 20940140
[TBL] [Abstract][Full Text] [Related]
6. The retinoic acid-metabolizing enzyme CYP26A1 upregulates fascin and promotes the malignant behavior of breast carcinoma cells.
Osanai M; Lee GH
Oncol Rep; 2015 Aug; 34(2):850-8. PubMed ID: 26058854
[TBL] [Abstract][Full Text] [Related]
7. Specific cellular immunity and antitumor responses in C57BL/6 mice induced by DNA vaccine encoding murine AFP.
Tian G; Yi JL; Xiong P
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):440-3. PubMed ID: 15313685
[TBL] [Abstract][Full Text] [Related]
8. The mouse chorionic gonadotropin beta-subunit-like (muCG beta l) molecule produced by tumor cells elicits the switch of T-cell immunity response from TH2 to TH1 in mice immunized with DNA vaccine based on rhesus monkey homologous CG beta (rmCG beta).
Shi SQ; Peng JP; Xu L; Yang Y; Chen Y
J Gene Med; 2005 Jan; 7(1):87-96. PubMed ID: 15517553
[TBL] [Abstract][Full Text] [Related]
9. [A DNA vaccine encoding the extracellular domain of porcine endoglin induces antitumor immunity in a mouse colon carcinoma model].
Jiao JG; Zhang YD; Li YN
Ai Zheng; 2005 Oct; 24(10):1179-83. PubMed ID: 16219129
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic and cell survival properties of the retinoic acid metabolizing enzyme, CYP26A1.
Osanai M; Sawada N; Lee GH
Oncogene; 2010 Feb; 29(8):1135-44. PubMed ID: 19935721
[TBL] [Abstract][Full Text] [Related]
11. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
12. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo.
Guojun W; Wei G; Kedong O; Yi H; Yanfei X; Qingmei C; Yankai Z; Jie W; Hao F; Taiming L; Jingjing L; Rongyue C
Endocr Relat Cancer; 2008 Mar; 15(1):149-59. PubMed ID: 18310283
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary observation on antitumor effect of HPV58 composite DNA vaccine].
Wang H; Yu JY; Li L
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):523-7. PubMed ID: 24284225
[TBL] [Abstract][Full Text] [Related]
14. Heparanase DNA vaccine delivered by electroporation induces humoral immunity and cytoimmunity in animal models.
Fu J; Zhao B; Dong Z; Sun Y; Luan H; Shen X; Gao X; Gong F; Li S; Song H
Vaccine; 2012 Mar; 30(12):2187-96. PubMed ID: 22240343
[TBL] [Abstract][Full Text] [Related]
15. Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.
Lladser A; Párraga M; Quevedo L; Carmen Molina M; Silva S; Ferreira A; Billetta R; G Quest AF
Immunobiology; 2006; 211(1-2):11-27. PubMed ID: 16446167
[TBL] [Abstract][Full Text] [Related]
16. Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.
Sypniewska RK; Hoflack L; Tarango M; Gauntt S; Leal BZ; Reddick RL; Gravekamp C
Breast Cancer Res Treat; 2005 May; 91(1):19-28. PubMed ID: 15868428
[TBL] [Abstract][Full Text] [Related]
17. Strong humoral response elicited by a DNA vaccine targeting gastrin-releasing peptide with optimized adjuvants inhibits murine prostate carcinoma growth in vivo.
Lu Y; Mekoo DJ; Ouyang K; Hu X; Liu Y; Lin M; Jin L; Cao R; Li T; Zhang Y; Fan H; Liu J
Endocr Relat Cancer; 2009 Dec; 16(4):1171-84. PubMed ID: 19648182
[TBL] [Abstract][Full Text] [Related]
18. CYP26A1 knockout embryonic stem cells exhibit reduced differentiation and growth arrest in response to retinoic acid.
Langton S; Gudas LJ
Dev Biol; 2008 Mar; 315(2):331-54. PubMed ID: 18241852
[TBL] [Abstract][Full Text] [Related]
19. Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3.
Lv J; Liu C; Huang H; Meng L; Jiang B; Cao Y; Zhou Z; She T; Qu L; Wei Song S; Shou C
Gene Ther; 2013 Aug; 20(8):834-45. PubMed ID: 23364316
[TBL] [Abstract][Full Text] [Related]
20. The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination.
Ni J; Schirrmacher V; Fournier P
Vaccine; 2010 Oct; 28(42):6891-900. PubMed ID: 20709006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
